Evidence map›Paper›PMID 32481618›Full record

ArticleMolecules (Basel, Switzerland)2020

Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells.

Martin Cagala, Lucia Pavlikova, Mario Seres, Karolina Kadlecikova, Albert Breier, Zdena Sulova

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Martin CagalaInstitute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 84505 Bratislava, Slovakia.
Lucia PavlikovaInstitute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 84505 Bratislava, Slovakia.
Mario SeresInstitute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 84505 Bratislava, Slovakia.
Karolina KadlecikovaInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237 Bratislava, Slovakia.
Albert BreierInstitute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 84505 Bratislava, Slovakia.
Zdena SulovaInstitute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská cesta 9, 84505 Bratislava, Slovakia.
Slovak Academy of Sciences · SKSlovak University of Technology in Bratislava · SK

Funding

Scientific Grant Agency of Slovak Ministry of Education and Slovak Academy of Sciences (VEGA) 2/0159/19, 2/0157/18, 2/0070/19, and 2/0122/17Slovak Research Agency ITMS 26230120009The Slovak Research and Development Agency APVV-15-0303, APVV-15-0641 and APVV-14-0334
6 · The paper itself

Abstract

Four new variants of L1210 cells resistant to endoplasmic reticulum (ER) stressors, tunicamycin (S

Indexed as

AnimalsBortezomibCell Line, TumorDrug Resistance, MultipleEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressLeupeptinsMiceThapsigarginTunicamycinVincristinebenzyloxycarbonylleucyl-leucyl-leucine aldehydeBortezomibEndoplasmic Reticulum Chaperone BiPHspa5 protein, mouseLeupeptinsThapsigarginTunicamycinVincristinebortezomibendoplasmic reticulum stressL1210 cellsMG-132multiple drug resistanceproteasomal activitythapsigargintunicamycinvincristine

Identifiers

PMID32481618
PMCPMC7321222
OpenAlexW3032829688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.